Incisional hernias post cytoreductive surgery/peritonectomy and hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis

[1] Sugarbaker PH(2006)New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7 69-76

[2] Chua TC(2012)Early and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy J Clin Oncol 30 2449-2456

[3] Moran BJ(2021)Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of peritoneal surface malignancies—An evidence-based review Curr Probl Cancer 45 100737-51

[4] Sugarbaker PH(2016)Cytoreductive surgery and peritonectomy procedures Indian J Surg Oncol 7 139-28

[5] Levine EA(2015)Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix Int Surg 100 21-596

[6] Glehen O(2013)HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy J Surg Oncol 107 591-492

[7] Gilly FN(2007)A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol 14 484-319

[8] Ray MD(2013)Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres J Surg Oncol 107 312-229

[9] Dhall K(2016)Complications of cytoreductive surgery and HIPEC in the treatment of peritoneal metastases Indian J Surg Oncol 7 225-263

[10] Mehta SS(2020)Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies Hernia 24 257-763

[1] Sugarbaker PH(2006)New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7 69-76

[2] Chua TC(2012)Early and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy J Clin Oncol 30 2449-2456

[3] Moran BJ(2021)Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of peritoneal surface malignancies—An evidence-based review Curr Probl Cancer 45 100737-51

[4] Sugarbaker PH(2016)Cytoreductive surgery and peritonectomy procedures Indian J Surg Oncol 7 139-28

[5] Levine EA(2015)Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix Int Surg 100 21-596

[6] Glehen O(2013)HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy J Surg Oncol 107 591-492

[7] Gilly FN(2007)A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol 14 484-319

[8] Ray MD(2013)Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres J Surg Oncol 107 312-229

[9] Dhall K(2016)Complications of cytoreductive surgery and HIPEC in the treatment of peritoneal metastases Indian J Surg Oncol 7 225-263

[10] Mehta SS(2020)Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies Hernia 24 257-763